# BlossomHill Therapeutics, Inc. Common Stock (BLSM)

> BlossomHill Therapeutics, Inc. Common Stock (BLSM) trades at $14.59 (-3.57%) as of 4:40:11 PM EST on Nov 18, 2026, +1.32% over the past month. Market cap is $463.74M, with 4.7 days to cover in short interest.

Canonical: https://massive.com/quote/blsm
Data as of: 2026-11-18T21:40:11.286Z (15-minute delayed)
Source: Massive (https://massive.com/docs/llms.txt)

## Price

**$14.59** -0.54 (-3.57%)
As of 4:40:11 PM EST on Nov 18, 2026 · 15-minute delayed
Nasdaq · usd

## Stock performance

How BlossomHill Therapeutics, Inc. Common Stock (BLSM) stock has performed from one day to one year, with its 52-week range.

| Period | Return |
| --- | --- |
| 1D | -3.57% |
| 1W | -9.49% |
| 1M | +1.32% |
| YTD | -8.81% |
| 1Y | -8.81% |
| 52-wk range | $11.02 – $27.99 |

From daily closes through Nov 18, 2026.

## Key statistics

Today's trading snapshot for BLSM: day range, open, previous close, volume and market cap.

| Measure | Value |
| --- | --- |
| Day range | $14.34 – $16.75 |
| Open | $15.17 |
| Prev close | $15.13 |
| Volume | 280.17K |
| Market cap | $463.74M |
| Shares out | 31.78M |

## Insider trading

[BlossomHill Therapeutics, Inc. Common Stock (BLSM) insider trading](https://massive.com/quote/blsm/insider-trading.md): open-market Form 4 buys and sells by BlossomHill Therapeutics, Inc. Common Stock insiders over the last 12 months.

## 8-K filings

Material corporate events BlossomHill Therapeutics, Inc. Common Stock has disclosed to the SEC on Form 8-K.

- Nov 12, 2026 · [Quarterly earnings](https://massive.com/quote/sec-filings/8-k/earnings-releases.md)
  “On November 12, 2026, BlossomHill Therapeutics, Inc. (the "Company") issued a press release announcing its financial results for the quarter ended September 30, 2026.”
- Sep 18, 2026 · [Quarterly earnings](https://massive.com/quote/sec-filings/8-k/earnings-releases.md)
  “On September 18, 2026, BlossomHill Therapeutics, Inc. (the "Company") issued a press release announcing its financial results for the quarter ended June 30, 2026.”
- Sep 15, 2026 · [Clinical trial results](https://massive.com/quote/sec-filings/8-k/clinical-trial-results.md)
  “On September 15, 2026, BlossomHill Therapeutics, Inc. issued a press release announcing updated data from the ongoing Phase 1/2 SOLARA trial of BH-30643 in non-small cell lung cancer (NSCLC) patients with secondary epidermal growth factor receptor (EGFR) resistance mutations such as EGFR C797S.”
- Aug 10, 2026 · Public offering
  “On August 10, 2026, the Company completed its IPO of an aggregate of 9,375,000 shares of common stock at a price to the public of $16.00 per share. The aggregate gross proceeds from the IPO, before deducting underwriting discounts and commissions and estimated offering expenses payable by the Company, were approximately $150.0 million.”

## Dividend history and stock splits

BlossomHill Therapeutics, Inc. Common Stock's recent dividend payments and stock splits.

### Dividends

No recent dividends.

### Splits

- 55-for-1 · Mar 16, 2006

## BLSM short interest

How heavily BLSM is shorted: shares short, days to cover and average daily volume.

| Measure | Value |
| --- | --- |
| Days to cover | 4.7 |
| Short interest | 590.13K |
| Avg volume | 126.89K |

As of Oct 30, 2026 · reported to FINRA twice monthly.

## About BlossomHill Therapeutics, Inc. Common Stock

BlossomHill Therapeutics Inc is a clinical-stage biopharmaceutical company applying its intentional, chemistry-based approach to develop small molecule medicines that address unmet medical needs in cancer treatment. Its product pipeline includes two clinical-stage programs: BH-30643, an investigational, non-covalent, macrocyclic, brain active, mutant-selective OMNI-EGFR inhibitor for the treatment of epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC), and BH-30236, an investigational macrocyclic CDC-like kinase (CLK) inhibitor being evaluated first in relapsed or refractory acute myeloid leukemia (R/R AML) and higher-risk myelodysplastic syndromes (HR-MDS), and the preclinical-stage product candidate BH-501284 targeting activated KRAS.

| Measure | Value |
| --- | --- |
| Exchange | Nasdaq |
| Market | stocks |
| Type | CS |
| Currency | USD |
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 71 |
| IPO | $16.00 on Aug 7, 2026 |

[BlossomHill Therapeutics IPO page](https://massive.com/quote/blsm/ipo.md)

[Company website](https://www.bhtherapeutics.com)

## FAQ

### What is the BlossomHill Therapeutics, Inc. Common Stock (BLSM) stock price today?

BlossomHill Therapeutics, Inc. Common Stock (BLSM) is trading at $14.59 (-3.57% on the day) as of 4:40:11 PM EST on Nov 18, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

### What is BlossomHill Therapeutics, Inc. Common Stock?

BlossomHill Therapeutics Inc is a clinical-stage biopharmaceutical company applying its intentional, chemistry-based approach to develop small molecule medicines that address unmet medical needs in cancer treatment.

### What is the short interest in BLSM?

As of Oct 30, 2026, BLSM has 590.13K shares short and 4.7 days to cover.

### What exchange is BLSM listed on?

BlossomHill Therapeutics, Inc. Common Stock (BLSM) trades on Nasdaq in USD, in the PHARMACEUTICAL PREPARATIONS industry.

## Live data

Prices here are 15-minute delayed. For real-time BLSM quotes and the full history behind this page, use the Massive API or MCP server:

- `GET https://api.massive.com/v3/snapshot?ticker.any_of=BLSM`

Requests need a Massive API key. API reference for agents: https://massive.com/docs/llms.txt. Connect an AI agent through the Massive MCP server: https://massive.com/docs/ai-tools.

## Related

- [BlossomHill Therapeutics, Inc. Common Stock (BLSM) insider trading](https://massive.com/quote/blsm/insider-trading.md)
- [SEC 8-K events](https://massive.com/quote/sec-filings/8-k.md)
- [Markets overview](https://massive.com/quote/index.md)

Nothing here is investment advice. Data and content are provided for informational purposes under the Massive Terms of Service: https://massive.com/terms
